SCHEMBL23675005

SCHEMBL23675005

CC1(C)Cc2cc(Nc3ccc4c(n3)CCCC4=O)ccc2NC1=O

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAP4K1 Q92918 2/20 0.42
GRM5 P41594 6/20 0.37
KIF11 P52732 3/20 0.37
BAZ2B Q9UIF8 1/20 0.36
MKNK1 Q9BUB5 1/20 0.35
MAOB P27338 3/20 0.35
MAOA P21397 2/20 0.35
NPC1 O15118 1/20 0.35
TSHR P16473 1/20 0.35
RAB9A P51151 1/20 0.35
SMN1; SMN2 Q16637 1/20 0.35
TNIK Q9UKE5 1/20 0.33
CA1 P00915 1/20 0.33
CA2 P00918 1/20 0.33
CA4 P22748 1/20 0.33
CA9 Q16790 1/20 0.33
PDE3B Q13370 1/20 0.32
PDE3A Q14432 1/20 0.32
ULK1 O75385 1/20 0.32
CRBN Q96SW2 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26445803 0.84 KIF11 (0.39) KIF11BAZ2BTNIKCRBN
SCHEMBL30100814 0.78 KIF11 (0.35) KIF11TSHRTNIKCRBN
SCHEMBL26088442 0.78 KIF11 (0.35) KIF11TSHRTNIKCRBN
SCHEMBL30100682 0.77 BCL6 (0.38) KIF11MKNK1TNIKCRBN
SCHEMBL23674636 0.77 BCL6 (0.38) KIF11MKNK1TNIKCRBN
SCHEMBL26086897 0.76 RHOA (0.40) KIF11NPC1RAB9ASMN1; SMN2TNIK
SCHEMBL23674757 0.75 EGFR (0.41) KIF11MKNK1SMN1; SMN2TNIKCRBN
SCHEMBL30100704 0.74 KIF11 (0.35) KIF11MKNK1TNIKULK1
SCHEMBL26089499 0.74 KIF11 (0.35) KIF11MKNK1TNIKULK1
SCHEMBL26089307 0.74 KIF11 (0.34) KIF11MKNK1TNIKULK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230128402-A1 HETEROCYCLIC COMPOUNDS AND USES THEREOF THE TRUSTEES OF PRINCETON UNIVERSITY 2023-04-27 US disclosed
US-20230128402-A1 HETEROCYCLIC COMPOUNDS AND USES THEREOF THE TRUSTEES OF PRINCETON UNIVERSITY 2023-04-27 US disclosed
WO-2021151062-A1 HETEROCYCLIC COMPOUNDS AND USES THEREOF THE TRUSTEES OF PRINCETON UNIVERISTY (US) 2021-07-29 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230128402-A1 HETEROCYCLIC COMPOUNDS AND USES THEREOF PAH, ALDH2, IDH2 MAP4K1 1207/4885GRM5 2769/4885KIF11 3560/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.